GWAS of Breast Events with Adjuvant Aromatase Inhibitors
Ancestry (1)
- structure_race - Genotypic race (phv00259433.v1.p1)
Anthropometry (1)
- BMI - Body mass index at baseline (phv00259416.v1.p1)
Demographics (1)
- age - Age at randomization (phv00259417.v1.p1)
Disease Events (16)
- breastevent - Event code for disease free survival analysis (phv00259429.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00259401.v1.p1)
- contralateral - Type of breast event - contralateral (phv00259428.v1.p1)
- distant - Type of breast event - distant (phv00259427.v1.p1)
- eventtype - Type of breast event (cases only) (phv00259432.v1.p1)
- length_of_trial_endocrine_therap - Length of time on endocrine therapy trial (in months) (phv00259424.v1.p1)
- local_regional - Type of breast event - local/regional (phv00259426.v1.p1)
- mango_1_allo2_cd - Treatment status (phv00259410.v1.p1)
- N_Stage__Pathologic - Pathologic N stage (phv00259421.v1.p1)
- perf_st - ECOG (Eastern Cooperative Oncology Group) performance score (phv00259419.v1.p1)
- Receptor_Status__ER - Estrogen receptor status (phv00259422.v1.p1)
- Receptor_Status__PgR - Progesterone receptor status (phv00259423.v1.p1)
- stra_chem_1 - Stratification factor: adjuvant chemotherapy (phv00259412.v1.p1)
- stra_hercep_1 - Stratification factor: herceptin use (phv00259415.v1.p1)
- T_Stage__Pathologic - Pathologic T stage (phv00259420.v1.p1)
- tnmstage - TNM stage (phv00259431.v1.p1)
General Health (2)
- bisphophonate_use - Bisphonate use (minimum of 30 days prior to recurrence) (phv00259425.v1.p1)
- frailty - Status Indicator of having Fracture (phv00259407.v1.p1)
Medications (2)
- stra_aspin_1n - Stratification factor: aspirin use (phv00259414.v1.p1)
- stra_celecox_1 - Stratification factor: celocoxib use (phv00259413.v1.p1)
Race and Ethnicity (1)
- race - Self-reported race (phv00259418.v1.p1)
Other (15)
- ANALYTE_TYPE - Analyte Type (phv00259436.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00259435.v1.p1)
- breastevent_survtime - Time from randomization to breast event for cases, and time from randomization to last follow-up for non-cases. (phv00259430.v1.p1)
- cohort_900 - Status Indicator of inclusion in 900 patient Cohort (phv00259408.v1.p1)
- GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00259439.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00259438.v1.p1)
- IS_TUMOR - Tumor status (phv00259437.v1.p1)
- RIKENcohort - Status indicator of MSK event (phv00259409.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00259434.v1.p1)
- SAMPLE_ID - Sample ID (phv00259404.v1.p1)
- SAMPLE_USE - Sample Use (phv00259405.v1.p1)
- stra_nod_1 - Stratification factor: lymph node status (phv00259411.v1.p1)
- SUBJECT_ID - Unique patient identifier (phv00259406.v1.p1)
- SUBJECT_ID - Subject ID (phv00259403.v1.p1)
- SUBJECT_ID - Subject ID (phv00259400.v1.p1)